Corbus Pharmaceuticals Holdings, Inc.
CRBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$40,209 | -$44,603 | -$42,347 | -$45,640 |
| Dep. & Amort. | -$2,739 | $641 | $1,488 | $1,639 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,145 | $0 | $5,720 | $9,480 |
| Change in WC | -$5,576 | $4,094 | -$4,024 | -$15,696 |
| Other Non-Cash | $585 | $3,768 | $1,618 | $2,034 |
| Operating Cash Flow | -$41,794 | -$36,100 | -$37,544 | -$48,184 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$13 | -$54 |
| Net Acquisitions | $0 | $0 | $8 | $0 |
| Inv. Purchases | -$180,804 | -$33,885 | -$86,342 | -$87,267 |
| Inv. Sales/Matur. | $59,494 | $69,527 | $116,421 | $13,880 |
| Other Inv. Act. | $0 | $0 | $0 | $24 |
| Investing Cash Flow | -$121,310 | $35,642 | $30,074 | -$73,417 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$15,480 | -$2,874 | -$534 | $58 |
| Stock Issued | $182,058 | $53 | $0 | $62,586 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$1,820 |
| Financing Cash Flow | $166,578 | -$2,821 | -$534 | $60,823 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $3,474 | -$3,279 | -$8,004 | -$60,777 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,394 | $17,195 | $25,677 | $86,453 |
| End Cash | $17,868 | $13,916 | $17,673 | $25,677 |
| Free Cash Flow | -$41,794 | -$36,100 | -$37,558 | -$48,238 |